Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Linxiaoxiao Ding"'
Autor:
Xiaolin Chen, Heng Huang, Hui Huang, Juanjuan Yong, Liling Zhu, Qianru Chen, Luyuan Tan, Yinduo Zeng, Yaping Yang, Jianli Zhao, Nanyan Rao, Linxiaoxiao Ding, Wenjing Wu, Yudong Li, Xiujuan Gui, Liming Ye, Yanlian Xu, Yumei Jiang, Linhong Su, Qiaozhen Xiao, Xueying Cai, Tingting Hu, Cui Tan, Qiongmei Liu, Shuyi Liu, Jinghua Zhao, Ying Wang, Fengyan Yu, Jian Zhang, Shunrong Li, Kai Chen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Oral corticosteroids represents the most prevalent treatment for idiopathic granulomatous mastitis. Ductal lavage with triamcinolone acetonide and antibiotics followed by observation (DL-OBS) has emerged as a novel strategy, but a comparison
Externí odkaz:
https://doaj.org/article/535ff0a978614a5e93badfe9878cd140
Autor:
Yongsheng Huang, Yuntan Qiu, Linxiaoxiao Ding, Shuwei Ren, Yuanling Jiang, Jiahuan Luo, Jinghua Huang, Xinke Yin, Sha Fu, Jianli Zhao, Kaishun Hu, Jianwei Liao
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract Breast cancers involving mutations in homologous recombination (HR) genes, most commonly BRCA1 and BRCA2 (BRCA1/2), respond well to PARP inhibitors and platinum‐based chemotherapy. However, except for these specific HR genes, it is not cle
Externí odkaz:
https://doaj.org/article/33507e326c1d43bfa0f940c2287cf57c
Autor:
Xiujuan Gui, Jianli Zhao, Linxiaoxiao Ding, Jie Chai, Hongna Lai, Yangyang Cai, Simin Luo, Yinduo Zeng, Wenjing Wu, Haizhu Chen, Herui Yao, Ying Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
AimThe aim of this study was to identify potential safety concerns associated with Sacituzumab Govitecan (SG), an antibody-drug conjugate targeting trophoblastic cell-surface antigen-2, by analyzing real-world safety data from the largest publicly av
Externí odkaz:
https://doaj.org/article/1b9cb54eb374426594cd350c25470d2b
Autor:
Wei Zhang, Qiannan Guo, Guoying Liu, Fang Zheng, Jianing Chen, Di Huang, Linxiaoxiao Ding, Xing Yang, Erwei Song, Yanqun Xiang, Herui Yao
Publikováno v:
PLoS Genetics, Vol 15, Iss 8, p e1008325 (2019)
The role of long non-coding RNA (lncRNA) in the progression of Nasopharyngeal carcinoma (NPC) has not been fully elucidated. The study was designed to explore the functional role of NKILA, a newly identified lncRNA, in the progression of NPC. We perf
Externí odkaz:
https://doaj.org/article/5413215d5dbb46e4aceb2f5ed3da97d6
Publikováno v:
Cancer Research. 83:OT3-25
Background: The HER2-targeted drugs selection after trastuzumab failure has become a challenging issue for HER2-positive metastatic breast cancer (MBC) patients. Inetetamab is a neotype of HER2-targeted monoclonal antibody with an engineered Fc segme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5915c9e5bee1d576f11c84009e0452ec
https://doi.org/10.1158/1538-7445.sabcs22-ot3-25-02
https://doi.org/10.1158/1538-7445.sabcs22-ot3-25-02
Autor:
Yi Chen, Qiuting You, Biaolin Wen, Linxiaoxiao Ding, Kai Chen, Jianli Zhao, Minhua Zeng, Fengxi Su
Publikováno v:
Cancer Research. 81:PS18-40
The Genomic Landscape of Chinese Breast CancerBackground : The comprehensive genomic profiling (CGP) through next-generation sequencing (NGS) brought a new understanding of breast cancer and provided more information about further clinical treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::914828c1cf49e6021c1538546efd5c93
https://doi.org/10.1158/1538-7445.sabcs20-ps18-40
https://doi.org/10.1158/1538-7445.sabcs20-ps18-40
Autor:
Linxiaoxiao Ding, Zhuofei Bi, Yaping Yang, Jianli Zhao, Yinduo Zeng, Kai Chen, Yunfang Yu, Guolin Ye, Danmei Pang, Wenjing Wu, Jie Chai, Herui Yao, Qian Hu, Ying Wang, Jun Tang, Xiao Lin, Xiujuan Gui, Donggeng Liu
Publikováno v:
Ann Transl Med
BACKGROUND: The overall survival (OS) among patients with advanced breast cancer (ABC) varies greatly. Although molecular subtype is known as the most important factor in OS differentiation, significant differences in OS among patients with the same
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5677da5d646b8671b9fcc2082f861ce6
https://doi.org/10.21037/atm-20-3473
https://doi.org/10.21037/atm-20-3473
Autor:
Yan-Qun Xiang, Linxiaoxiao Ding, Xiao Lin, Qian Hu, Danmei Pang, Nengtai Ouyang, Herui Yao, Yinduo Zeng
Publikováno v:
Cancer Medicine
Rho GTPase‐activating protein 42 was identified as an inhibitor of RhoA to maintain normal blood pressure homeostasis. However, the effect of ARHGAP42 in promoting cell malignancy in nasopharyngeal carcinoma is demonstrated in this study. Microarra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbeda6b57fe035faa3344b56fcd36ac
https://pubmed.ncbi.nlm.nih.gov/29936709
https://pubmed.ncbi.nlm.nih.gov/29936709
Autor:
Xing Yang, Qiannan Guo, Jianing Chen, Guoying Liu, Erwei Song, Herui Yao, Fang Zheng, Wei Zhang, Yan-Qun Xiang, Linxiaoxiao Ding, Di Huang
Publikováno v:
PLoS Genetics, Vol 15, Iss 8, p e1008325 (2019)
The role of long non-coding RNA (lncRNA) in the progression of Nasopharyngeal carcinoma (NPC) has not been fully elucidated. The study was designed to explore the functional role of NKILA, a newly identified lncRNA, in the progression of NPC. We perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155b2da8a684ca795881930ed9cdb13c
https://doi.org/10.1371/journal.pgen.1008325
https://doi.org/10.1371/journal.pgen.1008325